DB
PALI icon

Dmitry Balyasny’s Palisade Bio PALI Stock Holding History

Dmitry Balyasny’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.92M Sell
1,875,694
-1,395,151
-43% -$2.75M ﹤0.01% 1484
2026
Q1 		$5.72M Buy
3,270,845
+2,945,478
+905% +$5.36M 0.01% 1309
2025
Q4 		$765K Buy
+325,367
New +$625K ﹤0.01% 2319

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Dmitry Balyasny's PALI Position: Q2 2026 in Review

Dmitry Balyasny reduced its Palisade Bio (PALI) stake by 43% in Q2 2026, selling an estimated $2.75M and leaving 1,875,694 shares worth $3.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1484.

Dmitry Balyasny first reported a position in PALI in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.72M in Q1 2026. 123 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Dmitry Balyasny held 1,875,694 shares of Palisade Bio worth $3.92M as of Q2 2026.
  • Dmitry Balyasny sold 1,395,151 Palisade Bio shares in Q2 2026, an estimated $2.75M.
  • Palisade Bio made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #1484 holding.
  • Dmitry Balyasny first reported a position in Palisade Bio in Q4 2025 and has held it in 3 quarters since.
  • Dmitry Balyasny's Palisade Bio position peaked at $5.72M in Q1 2026.
  • 123 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.